Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers (TMB-108)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01292174
Recruitment Status : Completed
First Posted : February 9, 2011
Last Update Posted : December 18, 2012
Aaron Diamond AIDS Research Center
Bill and Melinda Gates Foundation
Information provided by (Responsible Party):
TaiMed Biologics Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2012
  Study Completion Date : September 2012